blinatumomab,ponatinib,venetoclax
otsuka,amgen,takeda,roche,astellas,incyte,abbvie
['blina ', 'ponatinib', 'venetoclax']
#ash2022 so far: ikzf1plus still important, tki's synergise with venetoclax, ponatinib+blina looks like a wonder combo for adult ph+all, and we might reduce therapy for prognostically favourable paediatric all subtypes (and some less favourable...). england lost.
Childhood Leukaemia Research. CLIP Group Co-Founder. Basketball & Softball Player (lousy, but enthusiastic). Born to Ride (Vespa).